IDEAYA Biosciences Price Target Maintained With a $53.00/Share by Oppenheimer

ideaya生物科學價格目標維持在$53.00/股，由Oppenheimer

道瓊斯 · 10/29 11:49 · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.